Effects of the protein kinase inhibitor, imatinib mesylate, on epithelial/mesenchymal phenotypes: implications for treatment of fibrotic diseases.

Source:http://linkedlifedata.com/resource/pubmed/id/17218487

Download in:

View as

General Info

PMID
17218487